卡兰博拉 W 通过STAT-3/BCL-XL信号通路抑制H1N1流感病毒诱导的氧化应激
Jingyao Su1, Jia Lai1, Jiali Li1
1Center Laboratory, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, No. 318 Renminzhong Road, Yuexiu District, Guangzhou 510120, China.
Viruses
|September 28, 2023
概括
胡卜素 W 是胡卜素中的天然黄酸,具有较低的毒性,并且有效地抑制了H1N1流感病毒的复制和氧化应激在体外,为H1N1感染提供了潜在的治疗方法.
科学领域:
- 病毒学 病毒学
- 自然产品化学 自然产品化学
- 药理学 药理学是指药理学的学科.
背景情况:
- H1N1流感病毒导致季节性爆发,导致严重的呼吸道症状和潜在的并发症,如肺炎.
- 开发有效的抗病毒药物来对抗H1N1对于公共卫生至关重要.
- 氧化应激和亡与H1N1病变发生有关.
研究的目的:
- 为了隔离和表征一种具有潜在抗H1N1活性的新型化合物.
- 为了评估隔离化合物在体外对H1N1流感病毒的疗效和安全性.
- 调查作用的潜在机制,包括对氧化应激和亡的影响.
主要方法:
- 从carambola提取和HR-ESI-MS表征一种来自carambola的黄类糖化物,命名为carambolaside W.
- 在体外评估卡兰博拉W的抗病毒活性对H1N1流感病毒复制.
- 通过西方斑点试验评估卡兰布拉 W 对 H1N1 诱导的氧化应激和与亡相关的蛋白质表达的影响.
主要成果:
- 卡兰博拉W被确定为一种具有显著抗H1N1流感病毒效应的黄类糖化物 (C47H58O2).
- 该化合物具有低毒性,并在体外有效抑制H1N1复制.
- 卡兰博拉W减轻了H1N1诱导的氧化应激和调节了与亡相关的蛋白质表达.
结论:
- 卡兰布拉 W 是一种有前途的低毒性天然黄,在体外对H1N1流感病毒有强烈的活性.
- 它通过抑制病毒复制,减少氧化应激和改变亡途径来起作用.
- 卡兰博拉 W 是治疗 H1N1 流感感染的潜在治疗候选药物.
相关概念视频
NF-κB-dependent Signaling Pathway
7.5K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
NF-κB-dependent Signaling Mechanism
The...
7.5K
Inhibition of Cdk Activity
4.8K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.8K
The JAK-STAT Signaling Pathway
9.0K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
9.0K


